SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

Market Cap	3.74B
Revenue (ttm)	954.68M
Net Income (ttm)	134.17M
Shares Out	n/a
EPS (ttm)	0.89
PE Ratio	27.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	25.55
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
RSI	56.54
Earnings Date	May 15, 2025

About BIT:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Glass Containers
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SXP

Financial Performance

In 2024, BIT:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.